OptimizeRx OPRX Increase in accrued expenses and other liabilities
Increase in accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about OptimizeRx's increase in accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OptimizeRx's increase in accrued expenses and other liabilities?
- OptimizeRx (OPRX) reported increase in accrued expenses and other liabilities of -$7.99M in Q1 2026.
- How has OptimizeRx's increase in accrued expenses and other liabilities changed year-over-year?
- OptimizeRx's increase in accrued expenses and other liabilities decreased by 1035.5% year-over-year, from $854K to -$7.99M.